Trade Pharma Network is an EU-licensed brokerage platform and international pharma-centric marketplace for buyers & sellers performing routine transactions of medicines. Its Artificial Intelligence (AI) driven platform uses powerful AI algorithms to enable efficient search & digital matchmaking between the platform key stakeholders but also Blockchain as it envisions a future where every physical medicine has a digital history, allowing Trade Pharma Network users to trace and verify its origins, attributes, and ownership to fight efficiently against counterfeit medicines, in Europe & Worldwide.

The Trade Pharma Network (TXP) will serve as the primary method of access to transactions on the Pharmaceutical Marketplace. The token will have the capability of being kept in the platform private wallet and then sent to the platform to facilitate transactions for services, avoiding the hassle of using a card of the outrageous fees of Bitcoin. The token is supported by Ethereum Blockchain and built on the ERC20 standard.

Team:

• Dr. Tyler I. Sainkoudje: Founder, President & CEO.  
• Marie N. Mendez: Chief Financial Officer. 
• Xavier Schneider: Pharma & Digital Health Expert. 
• Mahdi Boubakri: Chief Technical Officer. 

Trade Pharma Network ICO will begin on March 3, 2019. The ICO token supply represents 23% of the total token supply, so there is a total of 230,000,000 TXP tokens available, for 0.07 USD each. The ICO funding target is 2,500,000 USD, the funding cap is 20,000,000 USD and is expected to end on April 15, 2019 or when the funding cap is reached.

Token Reserve Split (77%):

• 35% Growth pool, operations, Marketing, Team;
• 25% Held by TXP;
• 15% Trade Pharma Network Team;
• 1% Referral;
• 1% Bounty.

Trade Pharma Network ICO features a bounty campaign.